# NextStat Commercial License Agreement

**Version 1.0 — Effective February 2026**

Copyright (c) 2024–2026 NextStat Inc. All rights reserved.

This Commercial License Agreement ("Agreement") is between NextStat Inc.
("Licensor") and the entity or individual agreeing to these terms ("Licensee").

The open-source version of this software is separately available under the
GNU Affero General Public License v3.0 (AGPL-3.0). See the LICENSE file.
This Agreement provides an alternative license for organizations that
require exemption from the AGPL-3.0 copyleft obligations.

For licensing inquiries: licensing@nextstat.io

---

## 1. Definitions

**"Software"** means the NextStat statistical computing engine, including all
source code, object code, libraries, bindings (Python, R, Rust, WASM), CLI
tools, documentation, and associated files distributed under this Agreement.

**"Enterprise Modules"** means the NS-Audit and NS-Compliance modules,
validation pack artifacts, and pre-compiled CRAN binaries available
exclusively to commercial licensees.

**"Derivative Work"** means any software that incorporates, links against,
or is based upon the Software or any portion thereof.

**"Authorized Users"** means the number of named individuals permitted to
use the Software as specified in the applicable Order Form.

**"Order Form"** means the purchase document executed by both parties
specifying the license tier, number of Authorized Users, fees, and term.

---

## 2. Grant of License

Subject to the terms of this Agreement and payment of applicable fees,
Licensor grants Licensee a:

(a) **Non-exclusive**, **non-transferable**, worldwide license to use,
    copy, modify, and create Derivative Works of the Software for
    Licensee's internal business purposes;

(b) Right to embed the Software or Derivative Works in Licensee's
    proprietary products and services **without** obligation to disclose
    source code under AGPL-3.0 Section 13 (network interaction) or
    Section 5 (modified source versions);

(c) Right to deploy the Software in validated (GxP) environments,
    containers, and CI/CD pipelines without source disclosure;

(d) Access to Enterprise Modules for the duration of the license term.

---

## 3. Restrictions

Licensee shall NOT:

(a) Redistribute, sublicense, sell, lease, or otherwise transfer the
    Software source code to any third party outside Licensee's organization;

(b) Remove, alter, or obscure any copyright, trademark, or attribution
    notices in the Software;

(c) Use Licensor's name, trademarks, or logos without prior written consent,
    except as required for reasonable attribution;

(d) Use the Software to provide a competing commercial statistical computing
    service (SaaS or hosted) without a separate Platform license;

(e) Reverse-engineer any proprietary Enterprise Module not provided in
    source form under this Agreement.

---

## 4. Fees and Payment

(a) Fees are as specified in the Order Form.

(b) All fees are due within thirty (30) days of invoice date.

(c) Fees are non-refundable except as expressly stated in this Agreement.

(d) Licensor may adjust fees upon renewal with sixty (60) days' prior
    written notice.

---

## 5. Support and Maintenance

(a) **Enterprise Tier**: Email support with 48-hour response SLA during
    business hours (Mon–Fri, 9:00–18:00 CET). Includes software updates,
    patches, and quarterly security advisories.

(b) **Platform Tier**: Dedicated channel (Slack/Teams) with 4-hour response
    SLA during business hours. Includes all Enterprise benefits plus
    on-site training (2 days/year) and early access to new features.

(c) Support does not include: custom model development (available separately),
    regulatory strategy consulting, or FDA/EMA submission preparation.

---

## 6. Intellectual Property

(a) Licensor retains all right, title, and interest in the Software,
    including all intellectual property rights.

(b) Licensee retains all right, title, and interest in Derivative Works
    created by Licensee, subject to Licensor's underlying rights in the
    Software.

(c) Nothing in this Agreement grants Licensee any rights to Licensor's
    patents, except the implied license to use the Software as permitted.

---

## 7. Warranty

(a) Licensor warrants that the Software will materially conform to its
    published documentation for ninety (90) days from delivery.

(b) If the Software fails to conform, Licensor will use commercially
    reasonable efforts to correct the non-conformance or provide a
    workaround.

(c) **THE SOFTWARE IS NOT WARRANTED FOR ANY PARTICULAR REGULATORY PURPOSE.**
    Licensee is solely responsible for determining the Software's
    suitability for use in regulatory submissions (FDA, EMA, PMDA, or
    other authorities). The validation pack and compliance documentation
    are provided as tools to assist Licensee's own qualification process.

(d) EXCEPT AS EXPRESSLY STATED ABOVE, THE SOFTWARE IS PROVIDED "AS IS"
    WITHOUT WARRANTY OF ANY KIND, EXPRESS OR IMPLIED, INCLUDING BUT NOT
    LIMITED TO WARRANTIES OF MERCHANTABILITY, FITNESS FOR A PARTICULAR
    PURPOSE, OR NON-INFRINGEMENT.

---

## 8. Limitation of Liability

(a) IN NO EVENT SHALL LICENSOR'S AGGREGATE LIABILITY UNDER THIS AGREEMENT
    EXCEED THE TOTAL FEES PAID BY LICENSEE IN THE TWELVE (12) MONTHS
    PRECEDING THE EVENT GIVING RISE TO LIABILITY.

(b) IN NO EVENT SHALL LICENSOR BE LIABLE FOR ANY INDIRECT, INCIDENTAL,
    SPECIAL, CONSEQUENTIAL, OR PUNITIVE DAMAGES, INCLUDING BUT NOT LIMITED
    TO LOSS OF DATA, LOSS OF PROFITS, BUSINESS INTERRUPTION, OR REGULATORY
    DECISIONS BASED ON SOFTWARE OUTPUT.

(c) The limitations in this Section apply regardless of the form of action,
    whether in contract, tort, strict liability, or otherwise.

---

## 9. Term and Termination

(a) This Agreement commences on the effective date specified in the Order
    Form and continues for the initial term stated therein.

(b) The Agreement automatically renews for successive one-year periods
    unless either party provides thirty (30) days' written notice of
    non-renewal before the end of the then-current term.

(c) Either party may terminate this Agreement immediately upon written
    notice if the other party materially breaches any provision and fails
    to cure such breach within thirty (30) days of receiving written
    notice.

(d) Upon termination:
    - Licensee must cease all use of the Software and Enterprise Modules;
    - Licensee must delete or return all copies of the Software source code;
    - Licensee may continue to use Derivative Works already incorporated
      into Licensee's deployed products for a wind-down period of six (6)
      months.

(e) Sections 6, 7(c), 7(d), 8, 10, and 11 survive termination.

---

## 10. Confidentiality

(a) Each party agrees to keep confidential any non-public technical or
    business information disclosed by the other party under this Agreement.

(b) Confidentiality obligations do not apply to information that:
    (i) is or becomes publicly available through no fault of the receiving
    party; (ii) was known to the receiving party prior to disclosure;
    (iii) is independently developed; or (iv) is required to be disclosed
    by law or regulation.

---

## 11. General Provisions

(a) **Governing Law**: This Agreement is governed by the laws of the State
    of Delaware, USA, without regard to conflict of law principles.

(b) **Dispute Resolution**: Any dispute shall be resolved by binding
    arbitration under the rules of the American Arbitration Association
    in Wilmington, Delaware.

(c) **Assignment**: Licensee may not assign this Agreement without
    Licensor's prior written consent, except in connection with a merger
    or acquisition of substantially all of Licensee's assets.

(d) **Entire Agreement**: This Agreement and the applicable Order Form
    constitute the entire agreement between the parties and supersede all
    prior agreements, representations, and understandings.

(e) **Severability**: If any provision is held unenforceable, the remaining
    provisions continue in full force and effect.

(f) **Waiver**: Failure to enforce any provision does not constitute a
    waiver of that provision.

(g) **Notices**: All notices must be in writing and sent to the addresses
    specified in the Order Form or to licensing@nextstat.io.

---

## 12. Tier Summary

| Feature | Community (AGPL-3.0) | Enterprise | Platform |
|---------|---------------------|-----------|----------|
| Core engine + all models | ✅ | ✅ | ✅ |
| Python / R (source) / Rust / WASM | ✅ | ✅ | ✅ |
| GPU acceleration (CUDA, Metal) | ✅ | ✅ | ✅ |
| AGPL copyleft exemption | ❌ | ✅ | ✅ |
| NS-Audit (21 CFR Part 11) | ❌ | ✅ | ✅ |
| NS-Compliance (IQ/OQ/PQ) | ❌ | ✅ | ✅ |
| Pre-built validation pack | ❌ | ✅ | ✅ |
| CRAN binary package | ❌ | ✅ | ✅ |
| Priority support (48h SLA) | ❌ | ✅ | ✅ |
| Unlimited seats (site license) | ❌ | ❌ | ✅ |
| nextstat-server (GPU API) | ❌ | ❌ | ✅ |
| Dedicated channel (4h SLA) | ❌ | ❌ | ✅ |
| On-site training | ❌ | ❌ | ✅ |
| Custom integration | ❌ | ❌ | ✅ |

---

> **NOTICE**: This document has not yet been reviewed by legal counsel.
> The terms above represent the intended commercial framework. A final
> legally binding version will be prepared before any commercial
> transactions. Contact licensing@nextstat.io for inquiries.
